These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12937342)

  • 1. Nasal bone hypoplasia: is it a common finding amongst chromosomally normal fetuses of southern Chinese women?
    Wong SF; Choi H; Ho LC
    Gynecol Obstet Invest; 2003; 56(2):99-101. PubMed ID: 12937342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of fetal nasal bone and aneuploidies at first-trimester nuchal translucency screening in unselected pregnancies.
    Zoppi MA; Ibba RM; Axiana C; Floris M; Manca F; Monni G
    Prenat Diagn; 2003 Jun; 23(6):496-500. PubMed ID: 12813765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11-14-week scan.
    Cicero S; Rembouskos G; Vandecruys H; Hogg M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2004 Mar; 23(3):218-23. PubMed ID: 15027007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between first trimester absence of fetal nasal bone on ultrasound and Down syndrome.
    Otaño L; Aiello H; Igarzábal L; Matayoshi T; Gadow EC
    Prenat Diagn; 2002 Oct; 22(10):930-2. PubMed ID: 12378580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
    Chen X; Chang Y; Cui HY; Ren CC; Yu BY
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absent nasal bone at 11-14 weeks of gestation and chromosomal defects.
    Cicero S; Longo D; Rembouskos G; Sacchini C; Nicolaides KH
    Ultrasound Obstet Gynecol; 2003 Jul; 22(1):31-5. PubMed ID: 12858299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound evaluation of fetal nasal bone at 11 to 14 weeks in a consecutive series of 1906 fetuses.
    Viora E; Masturzo B; Errante G; Sciarrone A; Bastonero S; Campogrande M
    Prenat Diagn; 2003 Oct; 23(10):784-7. PubMed ID: 14558019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal nasal bone and trisomy 21 in the second trimester.
    Viora E; Errante G; Sciarrone A; Bastonero S; Masturzo B; Martiny G; Campogrande M
    Prenat Diagn; 2005 Jun; 25(6):511-5. PubMed ID: 15968623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuchal translucency and nasal bone for trisomy 21 screening: single center experience.
    Monni G; Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C
    Croat Med J; 2005 Oct; 46(5):786-91. PubMed ID: 16158472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities.
    Nicolaides KH
    Am J Obstet Gynecol; 2004 Jul; 191(1):45-67. PubMed ID: 15295343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maxillary length at 11-14 weeks of gestation in fetuses with trisomy 21.
    Cicero S; Curcio P; Rembouskos G; Sonek J; Nicolaides KH
    Ultrasound Obstet Gynecol; 2004 Jul; 24(1):19-22. PubMed ID: 15229911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal nasal bone status in Chinese women undergoing first-trimester screening for trisomy 21.
    Leung TY; Sahota D; Chan LW; Law LW; Fung TY; Lau TK
    Am J Obstet Gynecol; 2008 Nov; 199(5):521.e1-5. PubMed ID: 18599011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks.
    Cicero S; Bindra R; Rembouskos G; Spencer K; Nicolaides KH
    Prenat Diagn; 2003 Apr; 23(4):306-10. PubMed ID: 12673635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuchal translucency and nasal bone in first-trimester ultrasound screening for aneuploidy in multiple pregnancies.
    Sepulveda W; Wong AE; Casasbuenas A
    Ultrasound Obstet Gynecol; 2009 Feb; 33(2):152-6. PubMed ID: 18985621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Likelihood ratios for fetal trisomy 21 based on nasal bone length in the second trimester: how best to define hypoplasia?
    Cusick W; Shevell T; Duchan LS; Lupinacci CA; Terranova J; Crombleholme WR
    Ultrasound Obstet Gynecol; 2007 Sep; 30(3):271-4. PubMed ID: 17721915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in nuchal translucency thickness in normal and abnormal karyotype fetuses.
    Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C; Monni G
    BJOG; 2003 Jun; 110(6):584-8. PubMed ID: 12798476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
    Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
    Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal nasal bone assessment in first trimester down syndrome screening.
    Has R; Kalelioglu I; Yuksel A; Ibrahimoglu L; Ermis H; Yildirim A
    Fetal Diagn Ther; 2008; 24(1):61-6. PubMed ID: 18504384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-trimester fetal nasal bone length in an ethnic Chinese population.
    Sahota DS; Leung TY; Chan LW; Law LW; Fung TY; Chan OK; Lau TK
    Ultrasound Obstet Gynecol; 2009 Jul; 34(1):33-7. PubMed ID: 19424993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant right subclavian artery: incidence and correlation with other markers of Down syndrome in second-trimester fetuses.
    Paladini D; Sglavo G; Pastore G; Masucci A; D'Armiento MR; Nappi C
    Ultrasound Obstet Gynecol; 2012 Feb; 39(2):191-5. PubMed ID: 21793087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.